Delivery Order SPE2DB24D2105-SPE2DB25FAQEA
- Not listed
- The Defense Logistics Agency awarded a $60,505.52 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $11,055.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $36,062.98 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pharmaceutical products, with performance in Conshohocken, Pennsylvania and ultimate completion by September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and serves as a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $11,857.96 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector pens, with performance completed in Conshohocken, Pennsylvania. The contract, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, utilized firm fixed-price pricing under a non-competitive set-aside arrangement. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,190.57 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on July 17, 2025, with an ultimate completion date of July 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $13,905.99 to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $18,045.99 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion targeted for June 2, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of the vendor's pharmaceutical supply relationship with DLA's medical procurement operations. The award falls...
- The Defense Logistics Agency awarded a delivery order valued at $171,809.01 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $4,704.11 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors under a firm fixed price contract type. The award was made on September 9, 2025, with an ultimate completion date of September 10, 2025, and represents a non-competitive set-aside. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $38,655.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injector medication. The contract, which was not set aside and was competitively awarded, was finalized on July 14, 2025, with an ultimate completion date of July 15, 2025. AmerisourceBergen will perform this delivery order from its corporate headquarters location in Conshohocken, Pennsylvania. This award represents a child delivery order under...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQEADelivery Order
The Defense Logistics Agency awarded a $43,050.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with a completion date of September 5, 2025. This contract represents a non-competitive award issued to the pharmaceutical distributor's Conshohocken, Pennsylvania facility and is classified as a child contract under a larger indefinite delivery vehicle. The delivery order leverages AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies available through its DLA contracts, including specialty medications, vaccines, and auto-injector delivery systems across multiple therapeutic domains. This delivery order for Enbrel, a biologic medication used to treat rheumatoid arthritis and other inflammatory conditions, reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through competitively established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.1k | 9/4/25 |